A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan Rogel Cancer Center

About this trial

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become "vigilant partners" in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.

Eligibility criteria

Qualifiers

Participants are adult patients (aged 18 years or older)

Diagnosed with lung, colorectal, breast, or prostate cancer

Are currently receiving active cancer treatments

Are self-managing one or more prescribed cancer medications

Disqualifiers

Can't access technology or do not use technology

Do not have access to the internet

Do not speak or read English

Not permitted to participate by their health care providers

Trial design

Treatments tested in this trial

  • Educational Intervention
  • Electronic Health Record Review
  • Follow-Up
  • Internet-Based Intervention
  • Interview
  • Survey Administration

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Michigan Rogel Cancer Center

Lead sponsor

Agency for Healthcare Research and Quality (AHRQ)

Collaborator